Correlation Between Black Diamond and Ventyx Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Ventyx Biosciences, you can compare the effects of market volatilities on Black Diamond and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Ventyx Biosciences.

Diversification Opportunities for Black Diamond and Ventyx Biosciences

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Black and Ventyx is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Black Diamond i.e., Black Diamond and Ventyx Biosciences go up and down completely randomly.

Pair Corralation between Black Diamond and Ventyx Biosciences

Given the investment horizon of 90 days Black Diamond Therapeutics is expected to under-perform the Ventyx Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Black Diamond Therapeutics is 1.32 times less risky than Ventyx Biosciences. The stock trades about -0.02 of its potential returns per unit of risk. The Ventyx Biosciences is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  218.00  in Ventyx Biosciences on October 25, 2024 and sell it today you would lose (2.00) from holding Ventyx Biosciences or give up 0.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Black Diamond Therapeutics  vs.  Ventyx Biosciences

 Performance 
       Timeline  
Black Diamond Therap 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Ventyx Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ventyx Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Ventyx Biosciences may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Black Diamond and Ventyx Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Black Diamond and Ventyx Biosciences

The main advantage of trading using opposite Black Diamond and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.
The idea behind Black Diamond Therapeutics and Ventyx Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.